In a 68- and 72-week clinical trial studying Wegovy (2.4 mg), brand-name Semaglutide, and Zepbound (15 mg), brand-name Tirzepatide, in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
As the use of these agents continues to expand, perioperative clinicians are increasingly encountering patients receiving medications such as semaglutide, liraglutide, dulaglutide, and tirzepatide before surgical and procedural interventions
This is referenced in Ayurveda as a herbal medicinal method, detailing the diseases of kapha and pitta [35]
Hopkins (eds.)
492 On the other hand, mutant p53 can upregulate the expression of multidrug resistance proteins (such as MDR1), leading to increased drug efflux and increased chemotherapy resistance